NEUP Neuphoria Therapeutics, Inc.: Sof aktivlar qiymati

Neuphoria (NEUP) kompaniyasining rasmiy ramzlari

Neuphoria Therapeutics Inc. (NEUP) kompaniyasining istiqbollari BNC210 ning xavotir buzilishlarini davolashdagi samaradorligiga va mahsulotni bozorga olib chiqish uchun hamkor qidiruviga bog'liq. Kotirovkalar umumiy bozor sikllarini hisobga olmagan holda yakuniy testlarga bog'liq va ko'rsatkich 0.02 darajasida turibdi. Ushbu grafikda aks etgan narxlar tendentsiyasi ushbu biotexnologiya loyihasining dinamikasini vizuallashtiradi, bunda tadqiqot ma'lumotlarining aniqligi dori vositalarini tashish uchun qat'iy harorat rejimiga rioya qilinishi bilan ta'minlanadi.

NEUP: Neuphoria Balans kapitallashuvi 25.12.2024 - 30.10.2026

NEUP (Neuphoria): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Aksiya narxi Neuphoria Therapeutics Inc.|NEUP - Maqsadli narxlar grafigi
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Bozor bahosi Neuphoria Therapeutics, Inc.|NEUP - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi haqida ma'lumot:
Bitta aksiya hisobiga xususiy kapital Neuphoria Therapeutics|NEUP - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti bionomics.com.au|NEUP - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Neuphoria Therapeutics Inc.|NEUP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Neuphoria Therapeutics Inc.|NEUP - Kompaniya qarzlari|Balans qiymatiga qarzlar Neuphoria Therapeutics, Inc.|NEUP - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Neuphoria Therapeutics|Shoshilinch likvidlik bionomics.com.au
- foyda va qiymat multiplikatorlari haqida ma'lumot:
NEUP - Sof daromad
Kompaniyaning dastlabki tahlili:NEUP, Neuphoria Therapeutics
bionomics.com.au seriyali mahsuloti

Neuphoria Therapeutics Inc. (NEUP) kompaniyasining sintez va sinov jarayonlarini to'liq autsorsing qilishga asoslangan virtual modeli kompaniyani tashqi moliyalashtirish va patentlarni boshqarishga bog'liq qilib qo'yadi. Kitob kapitalizatsiyasi qiymatining dinamikasi sof aktivlardan majburiyatlar ayirib tashlangan kundalik balansni aks ettiradi, bu esa investorlarga ushbu grafik tahlili orqali mablag'larning sarflanish sur'atini kuzatish hamda bankrotlik xavfi yoki ikkilamchi emissiya zaruriyatini baholash imkonini beradi.

Raqobatchilar tahlili

BIIB - Balans kapitallashuvi|Neurocrine Biosciences (NBIX) - Kompaniyaning balans qiymati|Sof aktivlar qiymati RGC (regencellbioscience.com)|Kompaniyaning balans qiymati Axsome Therapeutics, Inc.|Buxgalteriya kapitallashuvi ACAD (ACADIA Pharma)|Balans kapitallashuvi XENE|VKTX - Kompaniyaning xususiy kapitali|Supernus Pharmaceuticals - Kompaniyaning sof aktivlari|Balans kapitallashuvi catalystpharma.com CPRX|DNLI - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati HRMY (Harmony Biosciences Inc)|Biohaven Pharmaceutical (BHVN) - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali Amylyx Corp (AMLX)|Kompaniyaning balans qiymati Trevi Therapeutics|Buxgalteriya kapitallashuvi PRAX (praxismedicines.com)|Balans kapitallashuvi AVXL|CBLL - Kompaniyaning xususiy kapitali|prothena.com - Kompaniyaning sof aktivlari|Balans kapitallashuvi Alector Inc. ALEC|ANNX - Kompaniyaning balans qiymati|Sof aktivlar qiymati OMER|NGNE: Balans kapitallashuvi|AC Immune S.A. - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati Voyager Pharma|Kompaniyaning xususiy kapitali Neumora Corp NMRA|Kompaniyaning balans qiymati Scilex Holding Company (SCLX)|TVGN (tevogen.com) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi ACOG (Alpha Cognition Inc.)|Biznesning balans bahosi cogrx.com (CGTX)|Inhibikase - Balans kapitallashuvi|SAVA - Balans kapitallashuvi|ASRT (assertiotx.com) - Kompaniyaning sof aktivlari|Coya Therapeutics - Kompaniyaning buxgalteriya qiymati|Kompaniyaning sof aktivlari VTGN|OVID (Ovid Rx) - Jami sof aktivlar|Balans kapitallashuvi ABOS|CRVO (CervoMed Corporation) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi ATHE (Alterity Therapeutics Limited)|Clene Inc (CLNN) - Kompaniyaning xususiy kapitali|PEPG - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati JUNS (jupiterneurosciences.com)|RLMD: Balans kapitallashuvi|Annovis Bio Corporation (ANVS) - Balans kapitallashuvi|Kompaniyaning balans qiymati Grace Therapeutics Inc|fireflyneuro.com - Sof aktivlar qiymati|Balans kapitallashuvi KLTO|NRSN - Kompaniyaning xususiy kapitali|Reviva Pharmaceuticals Holdings - Kompaniyaning sof aktivlari|Balans kapitallashuvi MetaVia Inc. MTVA|NRXS: Kompaniyaning sof aktivlari|Helius Medical - Jami sof aktivlar|PASG: Balans kapitallashuvi|NERV - Biznesning balans bahosi|ATHA (Athira) - Balans kapitallashuvi|Kompaniyaning sof aktivlari Addex (ADXN)|Kompaniyaning balans qiymati Alzamend Neuro, Inc. (ALZN)|Biznesning balans bahosi cyclerion.com|Protagenic Therapeutics, Inc. - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati KTTA|Cortigent Medical - Balans kapitallashuvi|Biznesning balans bahosi Avenue Therapeutics Inc ATXI|Brainstorm Cell (BCLI) - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi CARA|CHRO (Chromocell Therapeutics Corp.) - Balans kapitallashuvi|Kompaniyaning sof aktivlari Eliem (ELYM)|Kompaniyaning sof aktivlari ITCI (Intra-Cellular Therapies)|Biznesning balans bahosi Longboard|Kompaniyaning balans qiymati Marinus Pharmaceuticals MRNS|NKGN: Buxgalteriya kapitallashuvi|NeuroBo Pharmaceuticals, Inc. - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Sage Therapeutics Inc.|SNPX (Neurotrope) - Kompaniyaning sof aktivlari|Trevena Inc (TRVN) - Balans kapitallashuvi|Kompaniyaning balans qiymati Vigil Neuroscience Inc.|Anew Medical Inc. - Sof aktivlar qiymati|Kompaniyaning balans qiymati Cerevel Therapeutics, Inc. (CERE)